April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Bayesian Estimation of the Performance of Frequency Doubling Perimetry (FDT), Confocal Scanning Laser Ophthalmoscopy (HRT) and GDx Variable Corneal Compensation (GDx-VCC) Scanning Laser Polarimetry for Glaucoma Screening in the Absence of a Gold Standard for Glaucoma Diagnosis
Author Affiliations & Notes
  • C. Eid
    Ophthalmology, Universite de Montreal, Montreal, Quebec, Canada
    Maisonneuve Rosemont Hospital Research Centre, Montreal, Quebec, Canada
  • G. Li
    Ophthalmology, Universite de Montreal, Montreal, Quebec, Canada
    Maisonneuve Rosemont Hospital Research Centre, Montreal, Quebec, Canada
  • O. Fontaine
    Ophthalmology, Universite de Montreal, Montreal, Quebec, Canada
    Maisonneuve Rosemont Hospital Research Centre, Montreal, Quebec, Canada
  • J. Lawrence
    5. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada
  • P. J. Harasymowycz
    Ophthalmology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
  • Footnotes
    Commercial Relationships  C. Eid, None; G. Li, None; O. Fontaine, None; J. Lawrence, None; P.J. Harasymowycz, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2738. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. Eid, G. Li, O. Fontaine, J. Lawrence, P. J. Harasymowycz; Bayesian Estimation of the Performance of Frequency Doubling Perimetry (FDT), Confocal Scanning Laser Ophthalmoscopy (HRT) and GDx Variable Corneal Compensation (GDx-VCC) Scanning Laser Polarimetry for Glaucoma Screening in the Absence of a Gold Standard for Glaucoma Diagnosis. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2738.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Diagnostic test evaluation is difficult for glaucoma because of the absence of a completely accurate gold standard. However, it is important for clinical and public health practices to have the best possible estimates of test performance parameters. We aim to study the validity of using a Bayesian approach to estimating the performance of glaucoma diagnostic tests in the absence of a gold standard.

Methods: : This cross-sectional, observational study included 600 subjects at high risk for glaucoma who underwent testing between January 2007 and October 2009 at a glaucoma clinic in Montreal, Quebec, Canada. Subjects underwent Matrix 24-2 frequency doubling perimetry (FDT), GDx variable corneal compensation (GDx-VCC) scanning laser polarimetry and confocal scanning laser ophthalmoscopy with the Heidelberg retina tomograph (HRT). The FDT was considered abnormal when there were 9 or more total deviation points less than 5%. A GDx-VCC nerve fiber index of 35 or greater was considered abnormal. The Moorfield’s regression analysis was used to define abnormality on HRT. We analyzed the data using a previously published Bayesian method whereby the marginal posterior densities of sensitivity (Se), specificity (Sp), positive predictive value (PPV) and negative predictive value (NPV) were estimated using the Gibbs sampler. Estimates were compared to those found in the literature using a gold standard.

Results: : The data from 500 subjects were analyzed. The estimates for the median Se-Sp combinations for the Matrix FDT, GDx-VCC and HRT were respectively: 0.67-0.80, 0.66-0.98, 0.77-0.57. The range of PPV was between 0.31 to 0.80. The NPVs ranged between 0.95 to 0.96.

Conclusions: : Using a Bayesian approach and no gold standard for glaucoma diagnosis, the HRTIII had the highest sensitivity, but the lowest specificity compared to Matrix FDT and GDx-VCC. The negative predictive values for all tests were high. Our estimates are similar to those found in the literature when similar test cutoffs and criteria are used. Bayesian approaches may be useful in estimating the parameters of diagnostic tests in glaucoma in the absence of a gold standard.

Keywords: clinical (human) or epidemiologic studies: biostatistics/epidemiology methodology • imaging/image analysis: clinical • perimetry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×